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              Abstract 
Background: Previous authors have reported thyroid dysfunction in human immunodeficiency virus (HIV)-infected 
individuals. Thyroid dysfunction may be a marker of severity or progression of HIV as reported by several studies.  
Aim and objective: To study prevalence of thyroid dysfunction and its correlation with CD4 count in HIV patients.  
Materials and methods: One hundred and fifty HIV positive patients were studied in ART center in the 
Department of Medicine at Gandhi Medical College and Hamidia Hospital, Bhopal. Thyroid profile (TT3, TT4, 
TSH, ft3 and ft4) were assessed along with CBP, ESR, LFT and RFT. Clinical examination and X ray chest and 
sputum examination done for confirmation or to rule out tuberculosis. Chemiluminescence assay was used for 
detection of thyroid function. 
Results: HIV infection was more prevalent in the age groups of 30-40 years (34.6%) and females. Prevalence of 
thyroid abnormality was 32%. Subclinical hypothyroidism was most common (18.66%) followed by clinical 
hypothyroidism (11.33%). Out of 80 patients with CD4 count <250, 21 had subclinical hypothyroidism. Out of 70 
patients with CD4 count >250, 7 had subclinical hypothyroidism.  
Conclusion: Thyroid dysfunction is highly prevalent in HIV patients’ mainly subclinical hypothyroidism. Routine 
thyroid function investigation is recommended in HIV patients.   
Keywords: thyroid function test, thyroid dysfunction, HIV infection, CD 4 count. 
This is an Open Access article that uses a fund-ing model which does not charge readers or their institutions for access and distributed under the 
terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly credited.  
Introduction 
 
Previous authors have shown an involvement of 
endocrine system in patients with human 
immunodeficiency virus (HIV) infection.[1] Abnormal 
thyroid function tests has become a routine practice in 
patients with HIV as compared to general population.  
(Beltran S 2003) Abnormal thyroid function tests 
includes sick euthyroid state, subclinical 
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hypothyroidism, hypothyroidism, Grave's disease, and 
thyroiditis.[2] Subclinical hypothyroidism is mainly 
reported in those on highly active anti-retroviral 
therapy (HAART).[3] Stavudine has been concerned in 
some studies. However, another study disprove this. 
Increased level of thyroxine-binding globulin (TBG) 
along with  alteration in normal serum T4 levels are 
reported to be significant marker of infection 
progression. [4-5] 
Evidences are lacking on the prevalence of thyroid 
dysfunction in HIV positive patients. Hence in present 
study we tried to study prevalence of thyroid 
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Materials and methods 
An observational cross sectional study was conducted 
on 15p HIV positive patients who were registered in 
ART center in the Department of Medicine at Gandhi 
Medical College and Hamidia Hospital, Bhopal.  
The study subjects were selected from amongst the 
patients of age 20-70 years who attended the Medicine 
OPD, special clinics or Medical Emergency Ward, Art 
center or are admitted in the medical wards in Hamidia 
Hospital, Bhopal. Pateints with liver disorders, renal 
disorders, congestive cardiac failure, pregnant women, 
patients on oral contraceptive pills, statins and other 
medications that alter thyroid functions and lipid levels 
were excluded from the study. Those patients who 
were under treatment for any thyroid disorder were 
also excluded from the study.  
From the study group baseline demographic data will 
be collected and a detailed physical examination was 
performed. Informed consent was obtained from all the 
study participants. The Institutional Ethics Committee 
approval was obtained before starting the study. 
Thyroid profile (TT3, TT4, TSH, ft3 and ft4) were 
assessed along with CBP, ESR, LFT and RFT. Clinical 
examination and X ray chest and sputum examination 
done for confirmation or to rule out tuberculosis. 
Chemiluminescence assay was used for detection of 
thyroid function. 
All the data analysis was performed using IBM SPSS 
ver. 20 software. Baseline characteristics of the study 
participants were expressed as mean ± standard 
deviation and percentage. Student t test was used to 
analyse difference in baseline characteristic of the 
study group. Chi Square test was used to analyze the 
association between HIV infection and thyroid 
dysfunction (both clinical and subclinical and 
association between HARRT and thyroid dysfunction. 




In present study HIV infection was more prevalent in 
the age groups of 30-40 years (34.6%) and females. 
Most common mode of transmission in both male and 
females was heterosexual, 55 (36.66%) males and 83 
(55.53%) females acquire infection by heterosexual 
route. Only 3 (2%) males were IV drug abusers.  Rest 2 
males (91.33%) and 7 females (4.665%) got infection 
by other routes. 
Out of 60 males, 37 were drives (22%), 13 (62%) 
males and 32 (35%) females were labor, 10 (16%) 
males and 18 (20%) females were farmer by 
occupation. 
Out of 150 patients included in present study, 102 
(68%) were found to be normal in investigation 
whereas 48 (32%) patients were found to have thyroid 
abnormality. Subclinical hypothyroidism was present 
in 28 (18.66%), 17 (11.33%) had clinical 
hypothyroidism, 2 (1.33%) had subclinical 
hyperthyroidism and 1 (0.66%) had clinical 
hyperthyroidism.  
 










20-30 2 3 0 0 
30-40 12 3 1 1 
40-50 6 4 1 0 
50-60 2 2 0 0 
>60 4 5 0 0 
Prevalence of subclinical hypothyroidism was more 
common in HIV patients in comparison to clinical 
hypothyroidism, Subclinical hyperthyroidism and 
Clinical hyperthyroidism. Most common age group in 
patients with subclinical hypothyroidism was 30-40 
years. 
Thyroid dysfunction was more prevalent in females in 
comparison to males. In patients with subclinical 
hypothyroidism, out of 28 patients, 16 were females 
and 12 were males. In clinical hypothyroidism patients 
9 were females and 8 were males. In subclinical 
hyperthyroidism, there were 2 patients both were 
females and in clinical hyperthyroidism there was 1 
patients and was female.   
Out of 28 patients of subclinical hypothyroidism, 20 
patients were found in ART group in comparison to 
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only 8 patients in non-ART group (p=0.01). Out of 17 
patients of clinical hypothyroidism 11 (7.3%) patients 
were under ART and only 6 (4%) were not on ART. 
Two patients out of 75 who had subclinical 
hyperthyroidism and no patients was found in non 
ART group. One patients with clinical hyperthyroidism 
was on ART.  
Table 2: Comparing CD4 count and thyroid abnormality 
Thyroid abnormality CD 4 count 
<250 (n=80) >250 (n=70) 
Present Absent Present Absent 
Subclinical hypothyroidism 21 59 7 63 
Clinical hypothyroidism 10 70 7 63 
Subclinical hyperthyroidism 2 78 0 70 
Clinical hyperthyroidism 1 79 0 70 
Out of 80 patients who had CD 4 count of less than 
250, 21 had Subclinical hypothyroidism whereas out of 
70 patients with CD4 count more than 250, 7 had 
Subclinical hypothyroidism. Of the 80 patients with 
CD4 count less than 250, 10 (6.66%) had clinical 
hypothyroidism whereas out of 70 patients with CD4 
count more than 250, 7 had clinical hypothyroidism.  
Out of 28 patients of subclinical hypothyroidism 20 
patients were presented with HIV TB coinfection 
compared to only 8 patients non TB HIV coinfection 
(p<0.001). Similarly out of 17 patients of clinical 
hypothyroidism 15 were with TB HIV coinfections and 
only 2 did not have this coinfection.  Two patients were 
with subclinical hyperthyroidism in which 1 was with 
HIV TB coinfection and 1 was with non TB HIV 
coinfections. The only patients of clinical 
hyperthyroidism had HIV TB coinfection.   
 
Discussion 
In present study 150 patients (70 males and 80 females) 
diagnosed with HIV infection were studied. The age 
ranged from 20-70 years with mean age was 35 years 
for males and 33 years for females. Majority of the 
patients were in the age group 30-40 comprising 52 
patients (27.33%) patients in present study. Carvalhoet 
al included 181 patients comprising 138 males and 43 
females. Male to female ratio was around 3.2:1 with 
mean age of around 34 years.[6] Low number of 
females may be due to the admission pattern in hospital 
and social pattern in our society where females are 
decreased to household activities and socialize less 
compared to males.  
In present study predominantly heterosexual 
transmission was observed. Out of 150 patients, in 138 
patients mode of transmission was heterosexual. 
Sokalskiet al studied a total of 52 patients, in all of 
them mode of acquisition of infection was 
heterosexual. Study conducted by Hakim et al showed 
that all patients were heterosexual and none were 
admitted to intravenous drug abuse. There were no 
haemophiliacs[7]. 
 
Prevalence of thyroid dysfunction in HIV patients 
The prevalence of thyroid dysfunction in HIV infected 
patients has been reported to range between 30 % to 35 
%. In present study out of 150 patients, 102 (68%) 
patients were found to be normal in investigations and 
rest 48 (32%) patients were found with thyroid 
abnormalities. Madge S et al had done a similar study 
in London teaching hospital including a total 1565 
patients. They showed that 75% of the patients had 
normal function whereas 25% patients were found with 
thyroid abnormality[4]. 
Thyroid dysfunction in HIV-positive individuals can 
result from gland destruction by opportunistic 
pathogens (Pneumocystis jirovecii or cytomegalovirus) 
or tumorigenic diseases (Kaposi's sarcoma). These 
opportunistic infections could be associated with the 
sick euthyroid syndrome or could cause low reverse 
T3[8].Pneumocystis thyroiditis has been reported to 
cause a painful low uptake thyroiditis like picture with 
hyperthyroidism followed by hypothyroidism[9]. In the 
present study out of 48 patients with thyroid 
abnormality, 28 females (18.66%) and 20 males 
(13.33%) were found to be with abnormal thyroid 
function. Meena LP et al evaluated the endocrine 
function in 150 HIV infected male patients at different 
levels of CD4 counts. They were divided into 3 groups 
on the basis of CD4 cell counts, out of that 40% of 
patients were found to be abnormal during 
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investigation[10]. Beltran et al conducted a cross 
sectional study to determine the prevalence and risk 
factors for hypothyroidism in 350 HIV infected 
patients grouped according to CDC staging. Prevalence 
of subclinical hypothyroidism was higher among HIV 
infected men than among HIV-infected women[11]. 
Screening studies have demonstrated an increased 
prevalence of hypothyroidism in HIV infected patients. 
Quinn T et al showed that an infectious trigger for 
immune activation (by molecular mimicry) is one of 
the postulated mechanisms for autoimmune disease. 
However hypothyroidism in HIV infected patients is 
not associated with autoimmunity. One case of 
Hashimoto's hypothyroidism has been reported so far 
after highly active anti-retroviral therapy (HAART) 
initiation[12]. 
 
Subclinical hypothyroidism in HIV infected patients 
In the present study prevalence of subclinical 
hypothyroidism was 18.6%. Out of 70 males 12 (8%) 
were diagnosed as a subclinical hypothyroidism, 
similarly out of 80 female patients 16 (10.6%) were 
diagnosed with subclinical hypothyroidism. 
Bongiovanniet al studied 190 patients and found 14.4% 
prevalence of subclinical hypothyroidism in HIV 
infected patients[13].Beltran S et al conducted a cross 
sectional study to determine the prevalence and risk 
factors for hypothyroidism in 350 HIV patients which 
were grouped according to CDC staging. Study showed 
that 16% patients of them had subclinical 
hypothyroidism[11]. 
Subclinical hypothyroidism has often been hued in the 
past few years in the HIV infected population, with a 
higher prevalence compared with HIV-negative 
individuals[14]. In patients with AIDS, a high 
prevalence of sick euthyroid syndrome has been 
reported, probably due to a hypothalamic-pituitary 
deficit related to the progression of irnunodeficiency 
and cachexia. Merenich et al conducted study on 46 
HIV patients. Finding of subclinical hypothyroidism 
was revealed in 8% of patients[15].Meena LP et al 
evaluated the endocrine function in 150 HIV male 
infected patients, 30% were found to have subclinical 
hypothyroidism[10].This difference in the prevalence 
may be due to different age sex distribution. Madge S 
et al had done a study to investigate the prevalence of 
overt and subclinical thyroid disease in HIV patients in 
2006 in London teaching hospital and determined the 
occurrence of thyroid dysfunction longitudinally over 
3yrs. Out of 1565 patients 4% had subclinical 
hypothyroidism. This study shows quite different and 
low prevalence of subclinical thyroid disease[4].This 
difference can be explain by the possibility of different 
sample size and prevalence may also be affected by 
duration of infection in patients included in the study. 
 
Clinical hypothyroidism in HIV infected patients  
The prevalence of clinical hypothyroidism in HIV 
infected patients in present study was found to be 17 
(11.33%). Out of that 8 were males and 9 were 
females, that means prevalence of clinical 
hypothyroidism in male and female was 6% and 5.6% 
respectively. Olivieri et al studied 119 HIV infected 
patients and reported a decreasing trend of thyroid 
hormones in these patients through different stages of 
infection. Primary hypothyroidism was found in 10% 
patients at symptomatic stages[16].Meena LP et al 
evaluated the endocrine function in 150 HIV infected 
patients at different levels of CD4 counts. Overall 10% 
had overt hypothyroidism[10].Madge S et al had done 
a similar study to investigate the prevalence of overt 
and subclinical thyroid disease in HIV positive patients 
and reported that out of 1565 patients 2.5% had overt 
hypothyroidism[4].Beltran S et al studied over 350 
patients and found 2.6% of clinical hypothyroidism. 
This variation in results may be because of large 
sample size[11]. 
 
Prevalence of subclinical hyperthyroidism in HIV 
infected patients  
The prevalence of subclinical hyperthyroidism in 
present study was 1.33% (both were females). In line 
with present study Beltran S et al also found subclinical 
hyperthyroidism in only 2 (0.57%) patients out of 350 
patients[11]. 
 
Prevalence of clinical hyperthyroidism in HIV 
infected patients  
In the present study prevalence of clinical 
hyperthyroidism was 0.6%. Only 1 patient of clinical 
hyperthyroidism was found, and that was a female. 
Beltran S et al study reported the incidence of clinical 
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hyperthyroidism as was 0.28 (22 cases/100 patient-
years for males and 0.55 cases/100 patient-years for 
females). The overall cross-sectional prevalence was 
1.1% (0.9% for males and 2.0% for females)[11]. 
Nelson M et al reported that thyroid dysfunction and 
relationship to antiretroviral, therapy in HIV-positive 
individuals in the HAART era[17]. 
 
Thyroid dysfunction and its correlation with 
HAART 
In the present study, in ART group, 34 patients were 
found with abnormal thyroid function and in non-ART 
group 14 patients were having abnormal thyroid 
profile. In ART group 20 (13.33%) patients had 
subclinical hypothyroidism, 11 (7.3%) had clinical 
hypothyroidism, 3 (1.33%) had subclinical hyper-
thyroidism, and 1 (0.66%) had clinical 
hyperthyroidism. In non-ART group, 8 (5.33%) 
patients had subclinical hypothyroidism, 6 (4%) had 
clinical hypothyroidism, and none had clinical or 
subclinical hyperthyroidism.  
Madge S et al studied a total 1565 patients (73% of the 
clinic population), of that 900 (58%) were on HAART 
at the start of the study. Thirty-nine (2.5%) were found 
to have overt hypothyroidism, and eight (<1%) had 
overt hyperthyroidism. Sixty one (4%) had subclinical 
hypothyroidism, five (<1%) had subclinical 
hyperthyroidism and 263 (17%) had a nonthyroidal 
illness[4].Bongiovanni M et al studied subjects on 
stable HAART (for at least 1 year) at baseline. At 
baseline, the prevalence of subclinical hypothyroidism 
was 14.4%[13]. In Grappin et al study a total of 212 
patients were included in the study. Twenty-six 
patients (12.3%) presented at least one abnormal test of 
thyroid function. On these no clinical dysthyroidism 
was noted. No hyperthyroidism was found. Biological 
thyroid dysfunction was assessed in 22 (10.4%) 
patients: 18 (8.5%) with subclinical hypothyroidism. In 
the study on HIV patients on HAART, result of the 
present study is comparable with other studies[14].As 
such hyperthyroidism was not found in previous 
studies, this discrepancy can be explained by difference 
in the immune status of the patient which depend on 
the duration, for which patients were on HAART.  
Furthermore the correlation between the immune 
reconstitution evaluated by increase in CD4 cells) and 
the occurrence of subclinical hypothyroidism might be 
considered. Although the occurrence of subclinical 
hypothyroidism in our study was more frequent in 
subjects starting HAART and was associated with a 
higher CD4+ cell recovery in the univariate analysis, 
when adjusting for the other variables this relationship 
was not confirmed. In Madeddu G et al study the role 
of HAART was also confirmed by a more recent 
report, which found that HAART interruption was 
associated with a normalization of thyroid tests[3]. 
 
Thyroid dysfunction in HIV patients and its 
correlation with CD4 counts  
In our study 80 patients were with CD4 count less than 
250 and 70 patients had CD4 count more than 250. Out 
of 80 patients of CD4 count less than 250, 34 patients 
had thyroid dysfunction. It was also observed that out 
of 70 patients with CD 4 count more than 250, 14 
patients had thyroid dysfunction. Subclinical 
hypothyroidism was present on 21 patients of CD 4 
count less than 250. Patients of clinical hypo-
thyroidism, 10 (6.66%) patients have CD4 count less 
than 250 and 7 (4.66%) patients have CD 4 count more 
than 250. 2(1.66%) patients were of subclinical 
hyperthyroidism, both were females. 1 (0.66%) patient 
was found of clinical hyperthyroidism and that was a 
female. Gagan Jain et al did a prevalence study of 
thyroid function changes, HIV infection at various 
stages of the illness. Fifty (n=50) subjects belonging to 
both newly diagnosed HIV positives were enrolled for 
the study. Results showed a direct correlation between 
CD4 count and free T4 values and an inverse 
correlation of CD4 counts with serum TSH levels. 
They concluded that thyroid dysfunction is frequent in 
HIV infection and with progression of disease there is a 
primary hypothyroid like stage[18]. Beltran el al found 
that subclinical hypothyroidism was associated with 
the use of stavudine and lower CD4+ cell 
count[11].Meena et al showed that TSH level is 
inversely proportionate to CD4 count[10]. 
 
Correlation of thyroid dysfunction in HIV infected 
patients and its correlation with tuberculosis  
Out of 28 patients of subclinical hypothyroidism, 20 
(13.3.%) patients were presented with HIV TB 
coinfection compare to only 8 (5.3%) patients non TB 
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HIV co infection, with P value of less than 0.001. 
Similarly out of 17 patients of clinical hypothyroidism 
15 (10%) patients were with TB HIV coinfection and 
only 2 (1.33%) patients were non TB group. 2 patients 
were with subclinical hyperthyroidism in which 1 
(0.66%) was in HIV TB group and 1(0.66%) was in 
non TB HIV group. 1 {0.66%} patient was found of 
clinical hyperthyroidism and that was a female.Hill et 
al reported that TB patients manifest the expected low 
T3 of non-thyroid illness, but, unlike most sick 
patients, usually have normal or increased serum 
binding of thyroid hormones[19]. 
 
Conclusion 
Thyroid hormone abnormalities are common in HIV-
infected individuals. Sick euthyroid syndrome and 
subclinical hypothyroidism were the abnormalities 
observed in this study. The frequency in which these 
abnormalities occurred was independent of whether the 
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